Trevor Burgess of C1 Financial and Jason Grenfell-Gardner of IGI Laboratories are part of a generation that doesn’t conceal sexual orientation. By James B. Stewart First Avenue Networks signs letter ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Teligent's lender is in an ongoing dispute with the company ...

Hikma, a London-based generics maker, paid $45.75 million to snap up the Canadian assets of Teligent, which filed for bankruptcy last October. The deal, which is expected to close by the end of the ...

Drug buyers are seeking court permission to continue a price-fixing lawsuit against Teligent Inc. despite the halt on litigation that kicked in when the drugmaker filed for bankruptcy. A group of drug ...

(Reuters) - Generic drugmaker Teligent Inc filed for bankruptcy protection on Thursday with plans to sell itself, citing "regulatory and legal setbacks" including a warning letter from the U.S. Food ...

Teligent Inc., a beleaguered generic drug maker, filed for court protection from creditors on Thursday with plans to sell itself. The publicly traded company listed assets of as much as $100 million ...

While still trying to address an FDA warning letter issued nearly two years ago, New Jersey pharma Teligent says it’s yanking a lot of its topical pain numbing treatment after testing found the med to ...

This call is available via webcast and can be accessed under News & Events in the Investor Relations section of Teligent, Inc.'s website at www.teligent.com. About Teligent, Inc. Teligent is a ...

Completes $77 million debt-for-equity exchange with Series C noteholders and senior secured lenders at premiums of 60% and 30% to the 5 day VWAP Please see Form S-3 (File No. 333-224188) and the ...

After trading relatively flat since late September, shares of Teligent (NASDAQ:TLGT) stock are soaring on Monday morning. Right now, there is no company-specific news to explain why TLGT stock is ...

BUENA, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company (the "Company"), announced today that its Special Meeting of ...